Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a written consent form agreeing to take part
- You are a native Finnish speaker
- Your hearing is normal for your age
- (For people receiving treatment): You have been diagnosed with a cancer that will be treated with the goal of curing it, using one of the following: cisplatin chemotherapy, oxaliplatin chemotherapy, cisplatin chemotherapy combined with radiation to the head and neck area, or radiation therapy to the head and neck area
Who may not be able to join:
- You are unable to sign a written consent form
- You currently have, or have previously had, a significant ear or hearing condition that has affected or could have affected your hearing
- You have a type of hearing loss where sound is blocked (conductive) or where one ear hears noticeably differently from the other (asymmetric), at any level of severity
- You have severe hearing loss in the inner ear (sensorineural)
- You have previously been treated for a cancer with chemotherapy or radiation therapy
- You have previously taken medications known to be harmful to hearing
- You have any significant illness or condition that the trial doctor believes could put you at risk or affect the trial results
- You have any condition that the trial doctor believes would make it difficult for you to follow the trial requirements
- (For people receiving treatment): You have an allergy or sensitivity to the trial medications or any of their ingredients
- (For people receiving treatment): You are pregnant, breastfeeding, or planning to become pregnant during the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tytti Willberg, PhD, Turku University Hospital
Phone: +358 2 313 5979
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Speech perception in noise
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.